沃森生物再度亮相CPHI欧洲展 积极拓展全球“朋友圈”

Core Insights - The 2025 CPHI event in Frankfurt showcased Watson Bio's significant presence and engagement with global partners, highlighting its commitment to expanding its international footprint [1] Group 1: Event Overview - The CPHI exhibition theme was "Shaping the Future of the Pharmaceutical Industry," featuring 2,400 exhibitors from 166 countries and approximately 62,000 professional visitors [1] - Watson Bio's booth size and display quality were notably enhanced, facilitating deeper interactions with global partners [1] Group 2: Business Development - Watson Bio engaged in productive discussions with over 20 existing clients from key markets including the Middle East, Central Asia, Latin America, Africa, Eastern Europe, South Asia, and Southeast Asia, strengthening existing partnerships [1] - The company successfully connected with dozens of potential clients, exploring collaboration opportunities around its existing products and pipelines, laying the groundwork for future market expansion [1] Group 3: International Recognition - Watson Bio's products have gained widespread international recognition, with successful exports to 24 countries [1] - The company is advancing over 30 international product registration projects, covering approximately 20 countries, indicating a robust international business strategy [1] Group 4: Future Outlook - Continuous participation in events from Milan to Frankfurt has demonstrated Watson Bio's growing influence in the global market [1] - The company aims to collaborate with global partners to contribute more to the establishment of a global health community [1]